Deals

Lilly to Acquire Centessa Pharmaceuticals to Advance Treatments for Sleep-Wake Disorders

Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, announces a definitive agreement for Lilly to acquire Centessa. Centessa is advancing a pipeline of orexin receptor 2 (OX2R) agonists designed to address […]

Lilly to Acquire Centessa Pharmaceuticals to Advance Treatments for Sleep-Wake Disorders Read More »

KKR and Taiyo Holdings Agree to Privatization to Accelerate Long-Term Growth

KKR, a leading global investment firm, and Taiyo Holdings Co., Ltd. (“Taiyo Holdings” or the “Company”; TSE stock code 4626), announce that KJ005 Co., Ltd. (the “Offeror”), an entity owned by investment funds managed by KKR, intends to make a tender offer to acquire all the common shares of Taiyo Holdings (the “Tender Offer”). Taiyo

KKR and Taiyo Holdings Agree to Privatization to Accelerate Long-Term Growth Read More »

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Biogen Inc. (Nasdaq: BIIB) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announce the companies have entered into a definitive agreement under which Biogen has agreed to acquire all outstanding shares of Apellis for $41.00 per share in cash at closing, or approximately $5.6 billion. Apellis stockholders will also receive a nontransferable CVR for each Apellis share

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology Read More »

Samsung Biologics Completes Acquisition of GSK’s Manufacturing Facility in Rockville, Maryland

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announces the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company’s first manufacturing presence in the United States. The Rockville site comprises two cGMP manufacturing plants with a combined 60,000-liter drug substance capacity, supporting both clinical

Samsung Biologics Completes Acquisition of GSK’s Manufacturing Facility in Rockville, Maryland Read More »

SALT Dental Partners Strengthens Greater Seattle Market with Haeger Orthodontics

SALT Dental Partners is pleased to announce its partnership with Haeger Orthodontics, a two-doctor orthodontic group serving the Greater Seattle market across two locations. This partnership adds further density in one of SALT’s most established regions, alongside Cascadia Kids Dentistry, Kirby Nelson Orthodontics, Pristera Orthodontics, Seattle Kids Dentistry, and Cascadia Smiles Orthodontics. Haeger Orthodontics represents

SALT Dental Partners Strengthens Greater Seattle Market with Haeger Orthodontics Read More »

Radon Medical Imaging Announces Acquisition of Majestic Medical Solutions

Radon Medical Imaging (Radon), a leading medical imaging equipment maintenance and repair services company, announces it has acquired Majestic Medical Solutions (Majestic), a trusted provider of medical imaging equipment services and solutions based in Baton Rouge, Louisiana. The transaction closed in the fourth quarter of 2025 and marks Radon’s fourth add-on acquisition, reinforcing its position

Radon Medical Imaging Announces Acquisition of Majestic Medical Solutions Read More »

Aviva Aesthetics Partners with Nationally Recognized Injector Jordan White and Urban Medical, Expanding into Arizona and Virginia

Aviva Aesthetics, a next-generation national medical aesthetics platform built on its proprietary Entrepreneur Equity™ model, announces a new partnership with Urban Medical, a luxury medical aesthetics and wellness practice founded by nationally recognized injector and educator Jordan White, BSN, RN, CNI, and co-owned by Katie Krahe, BS, MPH, MS-PA-C. The marks Aviva’s fifth new partnership

Aviva Aesthetics Partners with Nationally Recognized Injector Jordan White and Urban Medical, Expanding into Arizona and Virginia Read More »

MedReview Announces Acquisition of Vital Data Technology

MedReview, a leader in payment integrity solutions for health insurers, is proud to announce the acquisition of Vital Data Technology, the premier provider of advanced healthcare payer workflow and data technology. Founded in 2005, Vital Data Technology transforms the healthcare ecosystem by empowering stakeholders with predictive insights to improve member health and lower costs. The

MedReview Announces Acquisition of Vital Data Technology Read More »

Heartland Dental Affiliates with Dexter Dental Studio

In March, Heartland Dental continued expanding its national supported footprint, further advancing its commitment to providing support to providers offering world-class, comprehensive care. The organization collaborated to open five newly developed dental practices and welcome two affiliations, extending access to high-quality dental care in growing communities across the country. Heartland Dental’s affiliations with two practices

Heartland Dental Affiliates with Dexter Dental Studio Read More »

Vitalist Inc. Expands Global Wearable Footprint via Acquisition of Somatix, Adding Medical Grade AI and Remote Patient Monitoring to VitalOS™

Vitalist Inc. (TSX-V: VITA.V) (“Vitalist”), a wearable operating-system focused technology company, announces that it has entered into a definitive merger agreement dated March 30, 2026 (the “Merger Agreement”) to acquire 100% of the issued and outstanding equity securities of Somatix, Inc. (“Somatix”), a New York-based medical technology company focused on AI-powered remote patient monitoring (the

Vitalist Inc. Expands Global Wearable Footprint via Acquisition of Somatix, Adding Medical Grade AI and Remote Patient Monitoring to VitalOS™ Read More »

Scroll to Top